Papri Sarkar, M.D. 

Board Certified Board Certified

  • Obstetrics and Gynecology
  • Reproductive Endocrinology and Infertility Eligible
Sarasota Location Sarasota, FL
Brandon Location Brandon, FL
Tampa - Westshore Location Tampa - Westshore, FL
Schedule Appointment or 1-888-761-1967
Patient Testimonial
Shady Grove Fertility provides exceptional care and support under the expertise, knowledge and professionalism of Dr. Patounakis. He is incredibly successful at his work as well as thorough, compassionate and patient. I highly recommend Dr. Patounakis and the entire team at Shady Grove Fertility.

Biography

Papri Sarkar, M.D., is a Reproductive Endocrinologist and Infertility specialist at Shady Grove Fertility, Tampa Bay Area and Sarasota, Florida. Dr. Sarkar completed her residency in Obstetrics & Gynecology and subspecialty fellowship in Reproductive Endocrinology & Infertility at the University of South Florida, Tampa. 

Board‑certified in Obstetrics & Gynecology and board-eligible in Reproductive Endocrinology & Infertility, Dr. Sarkar provides compassionate, individualized care for patients navigating their family‑building journey. Her clinical focus includes ovarian aging, diminished ovarian reserve, fertility preservation, pre-implantation genetic testing, and fertility‑preserving surgeries such as myomectomy. Dr. Sarkar has published several peer-reviewed scientific manuscripts in leading scientific journals in the fields of reproductive endocrinology and infertility and reproductive surgeries.

Prior to her training in the United States, Dr. Sarkar’s international experience working as an OB/GYN in India and the United Kingdom enriches her global approach to reproductive medicine. She understands how physically, and emotionally demanding fertility treatment can be and considers it a privilege to support patients through each step—whether through surgical care, fertility preservation counseling, or navigating treatment options—with empathy, clarity, and empowerment.

Outside the clinic, Dr. Sarkar enjoys exploring national parks, experimenting with new recipes in the kitchen, practicing yoga and wellness, and cherishing time with her family. These passions underscore her belief that life’s most meaningful moments are those shared with loved ones.

Read More

Education

  • Residency: Obstetrics and Gynecology, University of South Florida, Tampa, Florida
  • Fellowship: Reproductive Endocrinology and Infertility, University of South Florida, Tampa, Florida
  • University of South Florida Research Award, 2024 
  • Kusum Lata Excellence Award, SRI 2023 Annual Meeting, Brisbane, Australia  
  • International Scholar Award (Medical Training Initiative), GMC, United Kingdom, 2015 
  • International Scholar Award (Medical Training Initiative), GMC, United Kingdom, 2015
  • American Society for Reproductive Medicine (ASRM)  
  • American College of Obstetricians and Gynecologists (ACOG)  
  • American Association of Gynecologic Laparoscopists (AAGL) 
  • Papri Sarkar, Monica Moore, Asli Ozmen, Busra Cetinkaya-Un, Vitko Julie, Anthony N Imudia, Charles J Lockwood, Umit A Kayisli, Ozlem Guzeloglu-Kayisli; Enhanced ovarian FKBP51 expression is associated with ovarian aging: a molecular insight for age-related fertility in women. PMID 39837475 
  • Monica Moore, Busra Cetinkaya-Un, Papri Sarkar, Umit A Kayisli, Nihan Semerci-Gunay, Michael Teng, Charles J Lockwood, Ozlem Guzeloglu-Kayisli; Depletion of Fkbp5 Protects Against the Rapid Decline in Ovarian Reserve Induced by Prenatal Stress in Female Offspring of Wild-Type Mice. PMID: 
  • Papri Sarkar, A Vest, M Baker, LS Hochberg; Ultrasound-Guided Polypectomy: Evaluation of a Novel Technique to Remove Endometrial Polyps in the Office. PMID: 39136395 
  • Papri Sarkar, Benjamin S. Harris, Kate Devine, Anthony Imudia, Phillip A. Romanski; Optimal anti-Mullerian hormone level in oocyte donors: a national database analysis; PMID: 37949348 (F & S Seminal article). 
  • Sarkar P, Romanski PA, Devine K. First Bologna, then Poseidon: What are we still missing to personalize care for patients undergoing assisted reproductive technology with a poor prognosis? Fertil Steril. 2023 Sep;120(3 Pt 2):615-616. doi: 10.1016/j.fertnstert.2023.06.028. Epub 2023 Jun 29. PMID: 37391060. 
  • Sarkar P, New EP, Sprague RG, Stillman R, Widra E, Jahandideh S, Devine K, Imudia AN. Live birth per embryo transfer with next generation sequencing preimplantation genetic testing: an analysis of 26,107 cycles. Syst Biol Reprod Med. 2023 Jun 2:1-8. doi: 10.1080/19396368.2023.2208253. Epub ahead of print. PMID: 37267227.
  • Sarkar P, New EP, Jindal S, Tanner JP, Imudia AN. The effect of trophectoderm biopsy for preimplantation genetic testing on fetal birth weight and preterm delivery. Minerva Obstet Gynecol. 2023 Jan 16. doi: 10.23736/S2724-606X.22.05196-X. Epub ahead of print. PMID: 36645423. 
  • Sarkar P, Jindal S, New EP, Sprague RG, Tanner J, Imudia AN. Role of preimplantation genetic testing for aneuploidy in a good prognosis IVF population across different age groups. Syst Biol Reprod Med. 2021 Oct;67(5):366-373. doi: 10.1080/19396368.2021.1954725. Epub 2021 Aug 6. PMID: 34355997. 
  • New EP, Sarkar P, Mikhail E, Plosker S, Imudia AN. Use of low dose vaginal misoprostol in office hysteroscopy: a pre-post interventional study. J Obstet Gynaecol. 2021 Aug;41(6):972-976. doi: 10.1080/01443615.2020.1820968. Epub 2020 Dec 2. PMID: 33962548. 
  • New EP, Sarkar P, Alvero RJ, Imudia AN. Improving the fellowship interview experience for reproductive endocrinology and infertility candidates: a survey. Fertility and Sterility. 2020 Apr 14;1(1):37-42. doi: 10.1016/j.xfre.2020.03.004. PMID: 34223210; PMCID: PMC8244322. 
  • Rishi A, Rollins M, Ahmed KA, Hunt DC, Sarkar P, Fernandez DC, Hoffman MS, Apte SM, Shahzad MMK, Chon HS, Chern JY, Wenham RM, Montejo ME. High-dose intensity-modulated chemoradiotherapy in vulvar squamous cell carcinoma: Outcome and toxicity. Gynecol Oncol. 2020 Feb;156(2):349-356. doi: 10.1016/j.ygyno.2019.11.027. Epub 2019 Nov 23. PMID: 31771865. 
  • Sarkar P, Ying L, Plosker S, Mayer J, Ying Y, Imudia AN. Duration of ovarian stimulation is predictive of in-vitro fertilization outcomes. Minerva Ginecol. 2019 Dec;71(6):419-426. doi: 10.23736/S0026-4784.19.04455-1. Epub 2019 Nov 13. PMID: 31741366. 
  • Mikhail E, Tamhane N, Sarkar P, Sappenfield E, Tanner JP, Imudia AN. Laparoscopic Entry Technique Using a Veress Needle Insertion with and without Concomitant CO2 Insufflation: A Randomized Controlled Trial. J Minim Invasive Gynecol. 2019 Nov-Dec;26(7):1383-1388. doi: 10.1016/j.jmig.2019.02.011. Epub 2019 Feb 23. PMID: 30802609.  
  • Sarkar P, Gandhi A, Plosker S, Ying Y, Mayer J, Imudia AN. Does supraphysiologic estradiol level during IVF have any effect on oocyte/embryo quality? A sibling embryo cohort analysis of fresh and subsequent frozen embryo transfer. Minerva Ginecol. 2018 Dec;70(6):716-723. doi: 10.23736/S0026-4784.18.04281-8. Epub 2018 Sep 26. PMID: 30264951. 
  • Mikhail E, Sarkar P, Moucharite M, Hart S. The Association Between Hospital Surgical Volume and the Uptake of Minimally Invasive Surgical Approach and Outpatient Setting for Hysterectomy. Surg Technol Int. 2018 Nov 11;33:191-196. PMID: 29985515. 
  • New EP, Sarkar P, Sappenfield E, Mikhail E, Plosker S, Imudia AN. Comparison of patients’ reported pain following office hysteroscopy with and without endometrial biopsy: a prospective study. Minerva Ginecol. 2018 Dec;70(6):710-715. doi: 10.23736/S0026-4784.18.04215-6. Epub 2018 May 31. PMID: 29856187. 
  • Sarkar P, Mikhail E, Hoyte L, Plosker S, Imudia AN. Electromechanical morcellators’ black-box warning: tribulations, expectations and solutions. Minerva Ginecol. 2018 Dec;70(6):761-773. doi: 10.23736/S0026-4784.17.04167-3. Epub 2017 Nov 21. PMID: 29161797. 
  • Sarkar P, Mikhail E, Schickler R, Plosker S, Imudia AN. Optimal Order of Successive Office Hysteroscopy and Endometrial Biopsy for the Evaluation of Abnormal Uterine Bleeding: A Randomized Controlled Trial. Obstet Gynecol. 2017 Sep;130(3):565-572. doi: 10.1097/AOG.0000000000002202. PMID: 28796688. 

Q&A

Growing up, I watched my father work tirelessly as an OB/GYN, providing compassionate care to women in need. His dedication and the profound impact he had on his patients inspired me to pursue medicine. I chose reproductive endocrinology because it combines cutting-edge science with deeply meaningful patient care—helping individuals and couples build families is both a privilege and a joy. 

At SGF, I’m proud to be part of a team that places patients at the center of everything we do. Whether it’s offering the latest innovations in reproductive technology or being part of national level research and having all kind of resources available for patient support, we go the extra mile to make care more accessible and personalized. It’s an environment where collaboration and empathy fuel success stories. 

I believe in first listening—truly listening—to where the patient is emotionally and physically. Then I aim to empower them with clear, evidence-based information and individualized recommendations. Fertility care isn’t one-size-fits-all, and I always honor each patient’s values and decisions. I also recognize the emotional toll fertility struggles can take and advocate for integrating mental health support as part of comprehensive care. 

Spirited, kind, and determined. I bring energy and empathy into every patient interaction, and I don’t give up when it comes to advocating for my patients’ goals. 

I treasure time with my family, and staying active through yoga and exercise. These moments recharge me and remind me of the importance of balance and joy in life. 

2025 Shady Grove Fertility

Also of interest